ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Antioxidant and anti-apoptotic effects of curcumin-loaded nanoliposomes against di-n-butyl phthalate-induced hepatorenal damage in rats.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hesperidin Mitigates Bisphenol-A Induced Oxidative Stress, Endocrine Disruption and Testicular Damage in Adult Male Wistar Rats.Journal of experimental pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Di-n-butyl phthalate (DBP) is a conventional plasticizer known to induce hepatotoxicity and nephrotoxicity through oxidative stress and apoptosis. In contrast, curcumin, a polyphenolic compound from Curcuma longa, has significant antioxidant and anti-apoptotic activity; however, its therapeutic efficiency is limited due to poor absorption and low bioavailability. Nanoliposomes can significantly enhance the stability and absorption of curcumin, thereby improving its protective efficacy. Therefore, this study aimed to evaluate the protective effects of curcumin-loaded nanoliposomes against DBP-induced hepatotoxicity and nephrotoxicity in rats. The adult male rats were randomly assigned to four groups: control, CUR-NLs (200 mg/kg/day), DBP (500 mg/kg/day), and DBP + CUR-NLs, for 60 days. DBP administration significantly raised blood levels of lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, uric acid, urea, and malondialdehyde (MDA), while lowering serum protein fractions and catalase (CAT) activity. Gene expression analysis revealed that nuclear factor erythroid 2-related factor 2 (Nrf2), Catalase (CAT), superoxide dismutase (SOD), and B-cell lymphoma-2 (BCL2) were downregulated, whereas cytochrome c (CYCS) and Bcl-2-associated X (Bax) were upregulated, and caspase-3 immunoreactivity increased. Compared with DBP-treated rats, co-treatment with CUR-NLs significantly restored protein metabolism, decreased lipid peroxidation, increased antioxidant defenses, raised anti-apoptotic markers, and improved histopathological and immunohistochemical findings. These results indicate that CUR-NLs effectively mitigate DBP-induced hepatorenal injury by restoring redox homeostasis and regulating apoptotic signaling pathways, suggesting that CUR-NLs represent a promising nanotechnological strategy for preventing DBP-induced organ toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.